|
Status |
Public on Jun 24, 2022 |
Title |
RET activation controlled by MAB21L4-CacyBP interaction in squamous cell carcinoma |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
|
|
Citation(s) |
35705526 |
Submission date |
Dec 14, 2021 |
Last update date |
Jun 24, 2022 |
Contact name |
Carolyn Lee |
E-mail(s) |
carilee@stanford.edu
|
Organization name |
Stanford University School of Medicine
|
Street address |
269 Campus Drive
|
City |
Stanford |
State/province |
CA |
ZIP/Postal code |
94305 |
Country |
USA |
|
|
Platforms (2) |
GPL11154 |
Illumina HiSeq 2000 (Homo sapiens) |
GPL16791 |
Illumina HiSeq 2500 (Homo sapiens) |
|
Samples (30)
|
|
This SuperSeries is composed of the following SubSeries:
|
GSE190864 |
CACYBP is required for epidermal homeostasis |
GSE190865 |
Enforced MAB21L4 expression enhances epidermal diferentiation |
GSE190866 |
MAB21L4 is required for epidermal homeostasis |
GSE191334 |
Bulk RNA-Seq of cutaneous squamous cell carcinomas (cSCC) with paired normal controls |
|
Relations |
BioProject |
PRJNA788908 |